Anti-ischemic and cognition-enhancing properties of NNC-711, a γ-aminobutyric acid reuptake inhibitor

European Journal of Pharmacology

Volumn 424, Issue 1, 2001, Pages 37-44

  O'Connell, Alan W ^a   Fox, Gerard B ^a   Kjoller, Connie ^a   Gallagher, Helen C ^a   Murphy, Keith J ^a   Kelly, John ^a   Regan, Ciaran M ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Avoidance conditioning; CA1 cell death; Carotid occlusion; GAT1 inhibitor; Spatial learning; Tiagabine

Indexed keywords

1 [2 (BENZHYDRYLIDENEAMINOOXY)ETHYL] 1,2,5,6 TETRAHYDRO 3 PYRIDINECARBOXYLIC ACID; SCOPOLAMINE; TIAGABINE;

AGED; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CAROTID ARTERY OBSTRUCTION; CLINICAL OBSERVATION; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; FEMALE; GERBIL; LATENT PERIOD; LEARNING; MALE; MAZE TEST; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

AMNESIA; ANIMALS; AVOIDANCE LEARNING; CELL SURVIVAL; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA ANTAGONISTS; GERBILLINAE; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; NIPECOTIC ACIDS; OXIMES; RATS; RATS, WISTAR; SCOPOLAMINE;

EID: 0035854553     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01116-5     Document Type: Article

References (43)

1. Neurotrophic factor-like effect of FPF1070 on septal cholinergic neurons after transection of fimbria-fornix in the rat brain
2. Effects of gamma-aminobutyric acid (GABA) on synaptogenesis and synaptic function
3. Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?
4. Tiagabine SK and F 89976-A, CI-966 and NNC-711 are selective for the cloned GABA transporter GAT-1
5. A GABA transporter operates asymmetrically and with variable stoichiometry
6. Benzodiazepines on trial: A research strategy for their rehabilitation
7. GABAergic influences on plus-maze behaviour in mice
8. Cholinergic and dopaminergic agents which inhibit a passive avoidance response attenuate the paradigm-specific increases in NCAM sialylation state
9. Memory consolidation induces a transient and time-dependent increase in the frequency of NCAM polysialylated cells in the adult rat hippocampus
10. The modulations of NCAM polysialylation state that follow transient global ischaemia are brief on neurons but enduring on glia
11. Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: Short-term study
12. Carrier-mediated GABA release activates GABA receptors on hippocampal neurons
13. GABA potentiation: A logical pharmacological approach for the treatment of acute ischaemic stroke
14. Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus
15. The γ-aminobutyric acid agonist-induced alterations in the ultrastructure of cultured cerebellar granule cells is restricted to early development
16. Postischemic inhibition of GABA reuptake by tiagabine slows neuronal death in the gerbil hippocampus
17. Enhancement of GABA neurotransmission after cerebral ischemia in the rat reduces loss of hippocampal CA1 pyramidal cells
18. Seizure-induced damage to the hippocampus is prevented by modulation of the GABAergic system
19. Cognitive effects of GABAergic antiepileptic drugs
20. Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: An interim report
21. Vigabatrin vs. carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study
22. Electrogenic uptake of gamma-aminobutryic acid by a cloned transporter expressed in Xenopus oocytes
23. Tiagabine
24. Molecular characterization of four pharmacologically distinct γ-aminobutyric acid transporters in mouse brain
25. Effects of gamma-aminobutryic acid on skate retinal horizontal cells: Evidence for an electrogenic uptake mechanism
26. Excitatory and inhibitory neurotransmitters in the generation and degeneration of hippocampal neuroarchitecture
27. Differential cognitive effects of carbamazepine and gabapentin
28. GABA induces functionally active low-affinity GABA receptors on cultured cerebellar granule cells
29. Effect of repeated treatment with a γ-aminobutyric acid receptor agonist on postnatal neural development in rats
30. Effects of gabapentin on cognition and quality of life in patients with epilepsy
31. Repetitive and transient increases in hippocampal neural cell adhesion molecule polysialylation state following multi-trial spatial training
32. Ameliorating effects of nefiracetam (DM-9384) on brain dysfunction
33. Spatial learning activates neural cell adhesion molecule polysialylation in a cortico-hippocampal pathway within the medial temporal lobe
34. Influence of nefiracetam on NGF-induced neuritogenesis and neural cell adhesion molecule polysialic acid expression: In vivo and in vitro comparisons
35. Potential antiepileptic drugs-tiagabine
36. Cultured neurons as model systems for biochemical and pharmacological studies on receptors for neurotransmitter amino acids
37. Progressive decrease in extracellular GABA concentrations in the post-ischemic period in the striatum: A microdialysis study
38. Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum
39. The γ-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy
40. NNC-711, a novel potent and selective γ-aminobutyric acid uptake inhibitor: Pharmacological characterization
41. Calcium-independent gamma-aminobutyric acid release from growth cones: Role of gamma-aminobutyric acid transport
42. Effects of aniracetam on one-trial passive avoidance tests and cholinergic neurons in discrete brain regions of rats